VMD updates guidance on QR codes for veterinary medicinal product packaging
Marketing Authorization Holders must update packaging and compliance processes to incorporate QR codes linked to educational materials as per the new guidelines.
Primary source: Redirecting
Introduction of the VigiFlow platform as the mandatory electronic reporting portal for submitting adverse events (AEs) and serious adverse events (SAEs) in South Africa.
This transition to a fully digital reporting platform enhances the efficiency and accuracy of safety data submissions, aligning South Africa with international pharmacovigilance standards.
Holders of Certificates of Registration and Clinical Research Organisations must update their safety databases and reporting workflows to comply with the new electronic reporting requirements for AEs and SAEs.
Regulatory Intelligence Lead
Review in the next regulatory intelligence cycle.
Introduction of VigiFlow as the primary electronic reporting portal; adoption of E2B reporting standards; updated technical specifications for submission of ICSRs from MAHs and SUSARs from clinical trial sponsors.
MAHs and clinical trial sponsors in South Africa will need to update their safety databases and reporting workflows to integrate with the VigiFlow platform. This represents a significant shift from current manual or paper-based processes to a fully digital E2B environment.
Holders of Certificates of Registration and Clinical Research Organisations must update their safety databases and reporting workflows to comply with the new electronic reporting requirements for AEs and SAEs.
The South African Health Products Regulatory Authority (SAHPRA) has initiated a consultation that requires all Holders of Certificates of Registration (HCRs) and Clinical Research Organisations (CROs) to transition to the VigiFlow platform for electronic safety reporting. This shift aims to modernize pharmacovigilance practices according to international E2B standards, necessitating updates to current manual reporting processes.
What changed: Introduction of the VigiFlow platform as the mandatory electronic reporting portal for submitting adverse events (AEs) and serious adverse events (SAEs) in South Africa.
Why it matters: This transition to a fully digital reporting platform enhances the efficiency and accuracy of safety data submissions, aligning South Africa with international pharmacovigilance standards.
Practical implication: Holders of Certificates of Registration and Clinical Research Organisations must update their safety databases and reporting workflows to comply with the new electronic reporting requirements for AEs and SAEs.
Published from the Firecrawl policy change extraction pipeline.
Marketing Authorization Holders must update packaging and compliance processes to incorporate QR codes linked to educational materials as per the new guidelines.
Monitor compliance practices regarding PAVA use in youth custody settings and assess alignment with the YJB's concerns and evidential claims on efficacy and safety.
Update product labels to include prevention indications for Capstar and Nitenpyram Tablets. Ensure that labeling reflects new usage guidelines for these products as outlined in the Emergency Use Authorization.
Review compliance with PREA obligations, prepare responses to any received non-compliance letters, and ensure any necessary deferral extension requests are properly submitted within the specified timeframe.